Measuring Life: From Single Cells to Liquid Biopsies

# Why better measurements change biology Watch the video first. Use this companion to revisit the reasoning and its evidence limits. The differences between cells. One number for a million cells hides which cells did what. Now shrink the volume. A chamber of about a nanoliter can hold a single cell, so its molecules aren't diluted into a whole tube. Smaller volumes mean fewer molecules, less averaging, and more control over individual cells and molecules. That's the promise of microfluidics: controlling tiny volumes of fluid in microscopic channels. Picture a laboratory's plumbing, shrunk onto a chip a few centimeters across. Sample enters at an inlet, flows through channels, is steered by valves, and is trapped in chambers, where it's measured. At this scale, flow is smooth and orderly, so liquids can be handled very precisely. In 2000, Quake's group reported soft, rubbery chips with valves built in. One channel crosses above another; pressurize the upper one, and it pinches the lower one shut, like stepping on a garden hose. In 2002, they scaled this up into what they called microfluidic large-scale integration: thousands of valves and hundreds of individually addressable chambers on one chip. Why does that matter? One chip can run many experiments in parallel, on tiny samples, automated by valves, with single cells isolated in chambers. Microfluidics is a broad field built by many groups; integrated valves were one contribution that made complex biological workflows possible on a chip. One payoff is digital PCR. PCR copies a DNA sequence; ideally, copies double each cycle, about two to the n after n cycles, though real reactions fall short. Digital PCR splits a sample across many tiny chambers, so most hold zero or one target molecule. Amplify, then count the chambers that light up. How much signal becomes how many molecules. In 2006, Quake and collaborators applied chip-based digital PCR to single cells, including bacteria from a termite's gut. The same instinct, watching individuals instead of averages, reached DNA sequencing. Most sequencing reads signals from many copied molecules at once. In 2003, the Quake lab read short stretches, up to five bases, from individual DNA molecules under a fluorescence microscope, watching labeled bases being added one at a time. The lab describes this as the first demonstration of single-molecule sequencing. The idea was then developed by a company, Helicos, whose 2008 paper, with Quake as a co-author, sequenced hundreds of thousands of single molecules without copying them. In 2009, Quake's lab used it to sequence an individual human genome. Today's dominant sequencers work differently, and modern sequencing came from many groups and companies, not from one lab. That's the lesson running through this course: a new measurement tool can open a new field. So the lab's recurring question isn't only, what biological phenomenon should we study? It's also: what measurement would make the answer visible? ## Evidence guide MEASUREMENT TECHNOLOGY and HISTORICAL TECHNOLOGY DEVELOPMENT: valves, molecular counting and individual-molecule sequencing change the observable. QUAKE-LAB PRIMARY RESULT, COLLABORATIVE PRIMARY RESULT and company development are distinct contributions; Quake did not invent all microfluidics or modern sequencing. Sources: [unger2000], [thorsen2002], [ottesen2006], [braslavsky2003], [harris2008]. See the course bibliography and claim audit.